Optimized HF Meds May Lessen MR Severity, Avoid Invasive Therapy

Patients with heart failure and mitral regurgitation should get at least 6 months of optimized guideline-directed medical therapy before invasive mitral repair is considered, researchers say.
Medscape Medical News